摘要 |
The invention provides compounds of the formulae (1), (2) and (3): (1, 2, 3), or salts, solvates or tautomers thereof; wherein G, A,v, m, X<SUP>a</SUP>, X<SUP>b</SUP>, X<SUP>c</SUP>, X<SUP>d</SUP>, X<SUP>e</SUP>, R<SUP>2</SUP>, R<SUP>3</SUP>, R<SUP>4</SUP>, Ar<SUP>1</SUP>, Ar<SUP>2</SUP>, R<SUP>6</SUP>, R<SUP>10</SUP>, R<SUP>11</SUP>, R<SUP>12</SUP> and R<SUP>13</SUP> are as defined in the claims. The compounds have activity against various kinases or, in the case of N-oxides, are reduced in hypoxic tissues to give compounds having kinase inhibiting activity. |
申请人 |
SENTINEL ONCOLOGY LIMITED;BOYLE, ROBERT, GEORGE;TRAVERS, STUART |
发明人 |
BOYLE, ROBERT, GEORGE;TRAVERS, STUART |